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Abstract 
Understanding the viability of the ischemic myocardial tissue is a critical issue in determining the 
appropriate surgical procedure for patients with chronic heart failure after myocardial infarction (MI). 
Conventional MI evaluation methods are; however, preoperatively performed and/or give an indirect 
information of myocardial viability such as shape, color, and blood flow. In this study, we realize the 
evaluation of MI in patients undergoing cardiac surgery by Raman spectroscopy under label-free 
conditions, which is based on intrinsic molecular constituents related to myocardial viability. We 
identify key signatures of Raman spectra for the evaluation of myocardial viability by evaluating the 
infarct border zone myocardium that were excised from five patients under surgical ventricular 
restoration. We also obtain a prediction model to differentiate the infarcted myocardium from the 
non-infarcted myocardium by applying partial least squares regression-discriminant analysis 
(PLS-DA) to the Raman spectra. Our prediction model enables identification of the infarcted tissues 
and the non-infarcted tissues with sensitivities of 99.98% and 99.92%, respectively. Furthermore, the 
prediction model of the Raman images of the infarct border zone enabled us to visualize boundaries 
between these distinct regions. Our novel application of Raman spectroscopy to the human heart 
would be a useful means for the detection of myocardial viability during surgery. 
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Introduction 
Understanding the viability of the ischemic myocardium is a critical issue for surgical treatment 
options for the failing heart after myocardial infarction (MI). Various functional evaluations of the 
heart are conducted preoperatively by, e.g., computed tomography, magnetic resonance imaging, 
radioisotope imaging, and echocardiography,1-4 to determine whether the ischemic myocardium has a 
potential to recover contractile functions after reestablishment of the coronary circulation.5,6 However, 
these diagnostic modalities are inadequate to detect precise, regional myocardial dysfunction in 
surgical situations, because of their relatively poor regional correlation with the real heart under direct 
vision. During heart surgery, viability of the myocardium is evaluated merely from the appearance of 
the heart in situ by reference to the indirect preoperative assessments. Thus, deeply desired is a useful 
means for intraoperative evaluation of the myocardial viability under direct vision to obtain better 
outcome of cardiac surgery. 
Raman spectroscopy is expected to be a valuable analytical tool in the biomedical research field, 
allowing label-free, functional imaging of biological samples via molecular vibrations with no need 
for fixation or staining.7-13 For over two decades, this modality has been applied experimentally to a 
variety of human tissues, e.g., the brain,14 coronary artery,15 skin,16 breast,17,18 and peripheral 
nerves.19-21 In heart tissue, however, the great challenge for clinical application of the conventional 
Raman spectroscopy is because of the weak signals. We previously reported Raman spectroscopic 
analysis of old myocardial infarct of rats created by coronary artery ligation by resonant scattering of 
cytochromes,22-24 which provides higher sensitivity and selectivity for the Raman signals as compared 
with the conventional Raman spectroscopy. The proper excitation wavelength, which is electronically 
resonant with the electronic transition of target molecules, allowed us to detect Raman spectra of 
cytochrome b5 and c in non-infarcted cardiac muscle of rat heart, having signal intensity 103 - 105 
times stronger than that of the non-resonance signal.9,25 In contrast to the rat experimental model, 
where infarcted tissues are distinctly replaced by fibrosis consisting mainly of type I collagen with no 
other major components,26 accurate Raman spectroscopic evaluation is quite difficult in human old MI 
because of the spectral complexity of the tissue constituents and lack of relevant characteristic 
molecules exhibiting the resonant Raman scattering in the infarcted tissues. Analogously, the human 
myocardium may more or less present different Raman spectra between non-infarcted and infarcted 
myocardium; however, still unclear are the definitive Raman spectral fingerprints and spectroscopic 
criteria for evaluation of human old MI. 
In this study, we sought to identify Raman spectral fingerprints and a prediction model for the 
evaluation of human old MI. To elucidate definitive Raman spectral fingerprints and a reliable 
prediction model for the evaluation of myocardial viability under the presence of noise in Raman 
spectrum, we employed a multivariate spectral analysis method, partial least squares 
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regression-discriminant analysis (PLS-DA). PLS-DA employs a wide region of Raman spectra to 
construct a prediction model, enabling the reduction of noise effect that appears in the whole Raman 
spectrum on the prediction model.23,27 Furthermore, the PLS-DA calculates latent variables (LVs) and 
scores, which gives us important spectral information for the prediction of tissue species.23,27 We 
successfully obtained Raman spectra of non-infarcted and infarcted regions of human myocardium 
resected for volume reduction from five patients with chronic ischemic cardiomyopathy under left 
ventricular reconstruction (LVR). Our novel application of Raman spectroscopy to the human heart 
would be a useful means for the detection of myocardial viability during surgery. 
 
Results 
Raman spectra of the myocardial tissue samples excised surgically from human heart 
The Raman spectra of the non-infarcted and infarcted myocardium showed their own distinct 
features (Figure 1). In all the specimens excised from 5 patients, the non-infarcted myocardium, 
which predominantly consists of cardiomyocytes, exhibited four evident Raman peaks at 755, 1133, 
1318, and 1590 cm-1 that were all assigned to heme proteins23 with no obvious differences among the 
patients (Figure 1b). In contrast, the Raman spectra of the infarcted myocardium were large in 
variation among the patients (Figure 1c). In addition, the infarcted myocardium had a spectral peak at 
2942 cm-1, which is distinct from the peak at 2934 cm-1 in the non-infarcted myocardium. The spectral 
shapes at 1248, 1453, 1661, and 2942 cm-1 were nearly identical to those of collagens (Supplemental 
Figure 1), a major constituent of the fibrotic tissue of old myocardial infarct, suggesting the presence 
of collagens in the infarcted myocardium as identified in our previous study on the rat heart.23 Similar 
to the non-infarcted myocardium, the four evident peaks assigned to heme proteins at 755, 1133, 1318, 
and 1590 cm-1 were also identified in the infarcted myocardium. 
We compared peak intensities of the four representative Raman bands at 755, 1133, 1318, and 
1590 cm-1 of the non-infarcted and infarcted myocardium (Figure 2). The intensities of non-infarcted 
myocardium were significantly larger than those of the infarcted myocardium, indicating that the 
relative contribution of molecular compositions assigned to these bands was much larger in the 
non-infarcted myocardium than in the infarcted myocardium. Predominant chemical components 
assigned to these Raman bands might be different in these two regions, i.e., cytochrome c in the 
non-infarcted myocardium and heme proteins other than cytochrome c in the infarcted myocardium as 
described in the Discussion section. As a result, the Raman bands of cytochrome c were significantly 
emphasized in the non-infarcted myocardium, and the intensity variance of non-infarcted myocardium 
among individual patients might indicate the interpatient variability of reduced cytochrome c in 
residual cardiomyocytes, which is an important index of viability of the myocardium. 
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Prediction of the myocardial tissue characteristics from single Raman bands 
We sought to predict tissue species by a simple approach using a single representative Raman 
band of non-infarcted and infarcted myocardium. We evaluated three representative Raman spectral 
features, i.e., peak intensity at 687 cm-1, peak intensity at 755 cm-1, and peak position ranging from 
2930 to 2950 cm-1.  
For the Raman band at 755 cm-1, prediction performance evaluated by using ROC analysis 
indicates that the sensitivities of non-infarcted and infarcted myocardium attained were 83.0% and 
87.6%, respectively (Figure 3a). Although high prediction performance was obtained with the area 
under the curve (AUC) of 94.0% by using the peak intensity at 755 cm-1, this Raman band reflected 
not only cytochrome c, but also the other heme proteins such as cytochrome b5, myoglobin, and 
hemoglobin23.  
To confirm the contribution of cytochrome c in the peak intensity at 755 cm-1, we obtained the 
peak intensity at 687 cm-1, which is one of the signatures of the presence of cytochrome c.23 However, 
prediction performance of the peak intensity at 687 cm-1 was quite low with the AUC of 62.8%, and 
the sensitivities of non-infarcted and infarcted myocardium were only 65.6% and 55.0%, respectively 
(Figure 3b). This indicates difficulty in confirming the presence of cytochrome c under the 
experimental conditions, i.e., 10-s exposure of 532-nm excitation at 235 to 300 µW/µm2. Higher 
signal-to-noise ratio detection with longer exposure time or higher excitation laser power would 
improve the prediction performance; however, long exposure time might perturb the procedures of 
cardiac surgery, and higher excitation laser power might induce photo-induced damage to the 
specimen. 
The peak position ranging from 2930 to 2950 cm-1 is also the representative signature of the 
difference between non-infarcted and infarcted myocardium, indicating the presence of collagen in the 
infarcted myocardium. The ROC analysis of the peak position provided the AUC of 88.1%. The 
sensitivities of non-infarcted and infarcted myocardium were 91.8 % and 80.8 %, respectively. 
These results indicated that the prediction of non-infarcted and infarcted myocardium was 
realized by using single Raman bands. The Raman bands representing the contribution of heme 
proteins (755 cm-1) and collagen (peak position around 2930 to 2950 cm-1) would be key signatures 
for the prediction of tissue species. However, prediction performance using a single band was limited 
in terms of signal-to-noise ratio of signal intensity. 
 
Reliable prediction for the discrimination of the infarcted myocardium from non-infarcted 
myocardium by PLS-DA 
To construct a more reliable prediction model for the evaluation of myocardial viability under the 
presence of noise in Raman spectrum, we employed a multivariate spectral analysis, PLS-DA. The 
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PLS-DA provides LVs and scores that reflect spectral features of non-infarcted and infarcted 
myocardium. The LVs provide common spectral features of a Raman spectral data set employed in 
PLS-DA in terms of the difference of tissue species. The scores on individual LVs represent the 
contribution of the LVs on each observed Raman spectrum. The LVs thus have implications for 
assignment of Raman bands in terms of the statistical differences between non-infarcted and infarcted 
myocardium when combined with scores of PLS-DA. Furthermore, the distribution of score plot 
indicates a similarity of the spectral data set of each tissue species and patient in terms of LVs, 
showing predictability of non-infarcted and infarcted myocardium. LVs and scores of PLS-DA 
calculated with a total of 10,000 Raman spectra of non-infarcted and infarcted myocardium in five 
patients are shown in Figure 4. 
Both scores of LV1 of the non-infarcted and infarcted myocardium of all patients were 
distributed in the negative value region (Figure 4a and Supplemental Movie 1). The scores of LV1 of 
the non-infarcted myocardium were smaller than those of the infarcted myocardium. The spectral 
peaks of LV1 included 1160, 1248, and 2942 cm-1, which represented specific Raman bands of 
infarcted myocardium (Figure 4b). Although a few specific spectral features of non-infarcted 
myocardium, such as 687, 1177, and 1366 cm-1, also appeared in LV1, the other specific spectral 
features of non-infarcted myocardium, such as 648, 2861, and 2934 cm-1, were not included in LV1. 
In LV2, the Raman bands included 648, 687, 1177, 1366, 2861, and 2934 cm-1, which were all 
specific in the non-infarcted myocardium, while no spectral feature of the infarcted myocardium 
appeared in LV2 (Figure 4c). The scores of LV2 of non-infarcted and infarcted myocardium were 
distributed in the positive region and negative region, respectively (Figure 4a and Supplemental 
Movie 1). As a result, LV1 and LV2 predominantly represented the important spectral features for the 
discrimination of non-infarcted and infarcted myocardium. Raman bands appearing in both the 
negative direction of LV1 and the positive direction of LV2 seemed to indicate the spectral features of 
non-infarcted myocardium. In contrast, Raman bands of LV1 in the negative direction with the 
subtraction of LV2 in the positive direction represented the spectral features of infarcted myocardium. 
In LV3, a derivative-like spectrum was obtained, especially representative Raman bands of heme 
proteins, such as 755, 1133, 1318, and 1590 cm-1 (Figure 4d). The scores of LV3 were roughly 
distributed depending on patients, not on tissue species (Figure 4a and Supplemental Movie 1). This 
result indicated that LV3 represented the difference among patients.  
By using the prediction model derived by the PLS-DA, we sought to predict tissue species of 
non-infarcted and infarcted myocardium. Cross-validated detection accuracy of non-infarcted and 
infarcted myocardium is shown in Table 1. High cross-validated sensitivities and specificities of 
99.98% and 99.92%, respectively, were obtained for the discrimination of non-infarcted and infarcted 
myocardium with the detection accuracy of 99.95%. This highly accurate detection capacity for tissue 
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species supported the notion that our findings for the spectral features in the LVs of PLS-DA provided 
important information about differences of the Raman spectra of tissue species. Furthermore, these 
results also demonstrated the fundamental feasibility of the Raman spectroscopy for the evaluation of 
old MI of patients on the basis of the constituent molecules. 
 
Raman imaging of myocardium of marginal region of myocardial infarction 
Raman imaging of non-infarcted and infarcted myocardium was performed by using PLS-DA. 
For reconstruction of Raman images, we obtained PLS-DA-predicted values defined as the scalar 
product of regression vectors of each tissue species at each pixel. Representative Raman images of the 
marginal area of non-infarcted and infarcted myocardium obtained from patient 3 revealed that the 
PLS-DA-predicted values of non-infarcted and infarcted myocardium highlighted these tissue species, 
and visualized the boundary of non-infarcted and infarcted myocardium (Figure 5). These tissue 
distributions were consistent with the histology confirmed by HE- and Azan-stained serial section. 
Furthermore, fibrotic tissues that were present among cardiomyocytes were also visualized. Similar 
images were obtained for all the tissues from the other 4 patients (data not shown). These results 
indicated that the Raman spectroscopy with the PLS-DA has a capability to visualize non-infarcted 
and infarcted myocardium of human myocardium without staining. 
 
Discussion 
Our previous studies provided a proof-of-principle demonstration of Raman spectroscopy for the 
label-free evaluation of MI by using rat samples.22,23 Here, we extended Raman spectroscopy to the 
human myocardium, and showed its feasibility for old MI by means of PLS-DA. We found that the 
Raman spectra of the human infarcted myocardium comprised various spectral components that did 
not appear in our previous rat study, while the spectral features of non-infarcted myocardium were 
almost identical to those in the rat.22,23 Such varieties of Raman spectra of human infarcted 
myocardium hampered the discrimination of infarcted myocardium from non-infarcted myocardium. 
In the present study, our multivariate analytical method enables the prediction of non-infarcted and 
infarcted myocardium with high prediction accuracy. 
In our previous study, we confirmed that strong Raman peaks at 755, 1133, and 1590 cm-1 of rat 
heart were assigned to the specific vibrational modes originated from a porphyrin ring in the center of 
heme proteins. In addition to these bands, the Raman bands at 648, 687, and 1366 cm-1 indicated the 
presence of reduced cytochrome c.23 Thus, the Raman spectra obtained from human non-infarcted 
myocardium that included these Raman bands also seemed to have arisen from reduced forms of 
cytochromes c in cardiomyocytes (Figure 1a). Reduced cytochrome c is generally present in viable 
cardiomyocytes. In contrast, there were no Raman bands at 648 and 687 cm-1 in the infarcted 
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myocardium, indicating the Raman bands at 755, 1133, and 1590 cm-1 were assigned to heme proteins 
other than cytochrome c, such as hemoglobin, myoglobin, and other cytochromes.23 Heme proteins 
are not common molecules in infarcted myocardium, which might appear by blood deposition during 
surgery or other contaminations following repair process of human old MI. As a result, patient 
variability of Raman spectra appeared in infarcted myocardium, but barely appeared in non-infarcted 
myocardium. 
The intensities of the Raman bands at 755, 1133, 1318, and 1590 cm-1 in non-infarcted 
myocardium tend to depend on the intensities of these Raman bands of non-infarcted myocardium 
(Figure 1). Especially in patient 4, large contribution of these Raman bands was obtained in the 
infarcted myocardium, and the intensities of these Raman bands in the non-infarcted myocardium 
were relatively larger than that in the other patients. This result indicated that the contributions of 
heme proteins appearing in the infarcted myocardium seemed to also appear in the non-infarcted 
myocardium; in other words, homogeneous background of the Raman spectrum of heme proteins 
might be present. The Raman spectra of non-infarcted and infarcted myocardium of each patient were 
obtained at near borders of MI, in which the distances between these observation points in 
non-infarcted and infarcted myocardium were within a few millimeters. One possible case for these 
homogeneous contributions of heme proteins in the non-infarcted and infarcted myocardium is the 
deposition of hemoglobin of blood. The myocardium was excised following LVR, thus blood must be 
exposed in the myocardium by hemorrhage following cardiac surgery. No red blood cells were 
observed in terms of HE-stained sections, indicating that the deposition of hemoglobin of hemolyzed 
blood might contribute to the Raman spectra in some cases. 
In Raman spectroscopy, visible or near-infrared excitation light is irradiated to the specimen and 
observed inelastic scattering light reflects molecular information about the myocardium via Raman 
spectrum. Since contrast agents and any preparation are not needed, Raman spectroscopy has 
potential for intraoperative observation with minimal invasiveness. Indeed, several groups initiated 
clinical trials of Raman spectroscopy for label-free in vivo diagnosis in the fields of breast surgery,28 
gastrointestinal surgery,29 and skin surgery.30 Although further confirmation of the Raman 
spectroscopic technique under in vivo condition is required for the application to cardiac surgery, we 
anticipate that label-free discrimination of non-infarcted and infarcted myocardium will allow us 
intraoperative evaluation of myocardial viability of human patients in the future. 
 
Conclusions 
This is the first report demonstrating the evaluation of old MI in patients undergoing cardiac 
surgery by means of Raman spectroscopy employing PLS-DA. Our results revealed the feasibility of 
the Raman spectroscopy for the label-free assessment of myocardial viability of human myocardium. 
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Our proposed approach may be a promising technique for direct evaluation of myocardial viability 
during surgery in the future. 
 
  
Methods 
Patients and sample preparation  
All experiments were performed with the approval of the Ethics Committee of Kyoto Prefectural 
University of Medicine (Permission No. RBMR-C-966). For all patients, fully informed consent was 
obtained after a full explanation of the study design and before the surgery. Myocardium was resected 
from five patients with old myocardial infarct under LVR at University Hospital, Kyoto Prefectural 
University of Medicine, conducted between August 2012 and January 2014 during cardiac surgery. 
The excised myocardium kept cold on ice was quickly transferred to the laboratory, embedded in 
frozen section compound (FSC 22; Leica, Wetzlar, Germany), snap-frozen in a freezing mixture 
(frozen carbon dioxide with acetone), and stored at -80°C until experiment. The frozen samples were 
sliced into 5-µm-thick sections with a cryostat microtome (CM1900; Leica). Three serial sections 
were obtained from each tissue for Raman and histological analysis. The sections for the Raman 
analysis were mounted on a 0.17-mm-thick cover glass without fixation. The sections for the 
histological analysis were subjected to hematoxylin and eosin (HE) staining or Azan staining to 
confirm histology. 
 
Raman spectroscopy 
Raman spectra and the reflecting spectral images were acquired with a slit-scanning confocal 
Raman microscope (RAMAN-11; Nanophoton, Osaka, Japan) as described previously.19,22,23,31 A 
frequency doubled Nd:YAG laser (532 nm) was employed for excitation. The excitation laser beam 
was focused into a line on a sample through a cylindrical lens and a high-magnitude water-immersion 
objective lens (UPLSAPO x60, NA = 1.2; Olympus, Tokyo, Japan) or a low-magnitude objective lens 
(UPlanFL N, x10, NA = 0.3; Olympus, Tokyo, Japan). The high-magnitude water-immersion 
objective lens was used for the acquisition of Raman spectra. These Raman spectra were also used for 
the construction of a prediction model with PLS-DA analysis in two-dimensional imaging. The 
low-magnitude objective lens was used for the acquisition of two-dimensional images. 
Raman scattered light was collected with the same objective lens. The Raman scattered light was 
focused onto the input slit with 70 µm width of the spectrometer with a 600 grooves/mm grating, and 
detected with a two-dimensional image sensor (Pixis 400BR, -70°C, 1340x400 pixels; Princeton 
Instruments, Trenton, NJ, USA). Owing to the line shaped focus of the excitation beam, a 
one-dimensional spectral image (one-dimensional space and Raman spectrum) from the 
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line-illuminated site was simultaneously obtained. Each pixel data in space was used for a single data 
point in all spectral analysis. Two-dimensional Raman spectral images were obtained by scanning the 
line-shaped laser focus in a single direction. The excitation laser power and the exposure time was set 
at from 235 to 300 µW/µm2 on the sample plane, and 10 s, respectively. 
 
Preprocessing of spectral analysis 
Before spectral analysis, all raw Raman spectra were calibrated using the known lines of ethanol.  
The broad fluorescence background was fitted with the modified least-squares polynomial curve32 and 
subtracted it from calibrated Raman spectra with Nanophoton software (Nanophoton, Osaka, Japan). 
The background-removed Raman spectra were normalized with the integrated intensity of each 
Raman spectrum. 
 
Statistical analysis of prediction capacity by means of a single band Raman spectrum 
The prediction capacity by means of a single band Raman spectrum was evaluated by using the 
peak intensity of 687 cm-1, peak intensity of 755 cm-1, and peak position of 2930 to 2950 cm-1. The 
peak intensities of 687 and 755 cm-1 were obtained in terms of area intensity as shown in 
Supplementary Figure 2 to extract proper intensity of each Raman bands. To extract peak position of 
2930 to 2950 cm-1 against noise contribution, Raman spectrum around 2940 cm-1 was fitted by 
Gaussian function in IGOR Pro software (WaveMetrics, OR, USA). Peak position comprised in the 
fitted Gaussian function was obtained for the statistical analysis. These spectral analyses were 
performed with programs written in programing language in MATLAB (Mathworks, Natick, MA, 
USA) and IGOR Pro software (WaveMetrics, OR, USA).  
Receiver operating characteristic (ROC) analysis was employed to predict tissue species by using 
single band of Raman spectrum. ROC analysis was performed with programs written in the IGOR 
programing language in IGOR Pro software (WaveMetrics, OR, USA). Optimal sensitivities of 
non-infarcted and infarcted myocardium were defined as those yielding the minimal value for 
(1-sensitivitynon-infarcted)2 + (1-sensitivityinfarcted)2, where sensitivitynon-infarcted and sensitivityinfarcted 
respectively indicated the sensitivities of non-infarcted and infarcted myocardium. 
 
PLS-DA analysis for the prediction of tissue species 
PLS-DA analysis was employed for the construction of a prediction model of old MI. PLS-DA 
analysis is widely applied to construct quantitative prediction model for classification in spectral 
analysis by projecting the predicted and observable variables into a new space to maximize the 
covariance between the response and independent variables. All calculations in PLS-DA were 
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performed with PLS toolbox (eigenvector Research, WA, USA) in MATLAB (Mathworks, Natick, 
MA, USA).  
Randomly obtained 1000 Raman spectra in each tissue species of each patient were analyzed. 
Since the cover glass retaining frozen sections exhibited Raman spectra from around 850 to 1020 cm-1, 
and Raman-silent region from around 2000 to 2800 cm-1 exhibited no significant Raman spectra in 
myocardium, we extracted Raman spectra from 596 to 836 cm-1, from 1024 to 1723 cm-1, and from 
2818 to 2980 cm-1 of each individual spectrum for PLS-DA analysis. We constructed a prediction 
model with orthogonal condition and calculated LVs and scores. Leave-one-out cross validation 
analysis was employed for the verification of the predictive accuracy of the prediction model using 
PLS-DA33-35. The optimal number of LVs used in the prediction model was determined as first 
minimum value of number of misclassification rate as shown in Supplementary Figure 3.  
For reconstruction of two-dimensional Raman images, we obtained the PLS-DA-predicted values 
defined as the scalar product of a regression vector with the Raman spectrum at each pixel. Original 
Raman spectral-images were obtained with 400x100 pixels in spatial dimension, and were binning 
The regression vector was derived by PLS-DA analysis in the construction process of a 
prediction model as shown above. The Raman spectra of 596 to 836 cm-1, from 1024 to 1723 cm-1, 
and from 2818 to 2980 cm-1 were used for the reconstruction of two-dimensional prediction map of 
tissue species.  
 
Raman spectroscopy of pure chemical of collagen 
Powdered collagen type I derived from bovine Achilles tendon (C9879, Sigma-Aldrich, MO, 
USA) was placed on a slide glass, and observed a Raman spectrum using the slit-scanning confocal 
Raman microscope as shown above. 
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Table 1. Detection power of non-infarcted and infarcted myocardium. Detection accuracy for the 
prediction of non-infarcted and infarcted myocardium was 99.95%. 
 Histology 
 Non-infarcted Infarcted 
Non-infarcted 
Infarcted 
4999 
1 
4 
4996 
Sensitivity 99.98% 99.92% 
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Figure 1. Raman spectra of the border zone myocardium obtained from 5 patients. (a) A representative 
HE-stained image of the boundary between the infarcted region (dashed area A) and non-infarcted 
region (dashed area B) of the heart tissue excised from patient 3. Scale bar represents 1 mm. 
Representative Raman spectra of non-infarcted myocardium (b) and infarcted myocardium (c) of each 
patient. Each spectrum was normalized by the integrated intensity of each Raman spectrum. 
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Figure 2. Peak intensities of representative Raman bands of the non-infarcted and infarcted 
myocardium obtained from 5 patients at 755 cm-1 (a), 1133 cm-1 (b), 1318 cm-1 (c), and 1590 cm-1 (d). 
Asterisks indicate significant differences (p < 0.01) by Student’s t test.  
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Figure 3. ROC analysis for the prediction of non-infarcted and infarcted myocardium of 5 patients by 
using representative Raman bands. Peak intensity of 755 cm-1 (a), peak intensity of 687 cm-1 (b), and 
peak position around 2930-2950 cm-1 (c) were used for the ROC curve calculation.  
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Figure 4. PLS-DA of non-infarcted and infarcted myocardium. (a) Score plot of LV1, LV2, and LV3. 
Triangle, non-infarcted cardiac tissue; circle, infarcted cardiac tissue; red, patient 1; green, patient 2; 
blue, patient 3; yellow, patient 4; and purple, patient 5. Contributions of LV1 (b), LV2 (c), and LV3 
(d) to Raman spectra are 78.65%, 2.56%, and 0.41%, respectively. 
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Figure 5. Representative 2D Raman images of a marginal region of non-infarcted and infarcted 
myocardium. (a, b) Two representative marginal regions of non-infarcted and infarcted myocardium 
of patient 3. Raman images at the dashed squares indicated in the HE-stained images were 
reconstructed by using PLS-DA-based prediction of tissue species. Scale bars in the HE-stained and 
Raman images in (a) and (b) are 200 µm and 100 µm, respectively. 
 
